The landscape of dementia prognosis has evolved radically with the advent of refined biomarkers, together with amyloid PET scans, tau imaging, and blood-primarily based exams that could detect Alzheimer's pathology yrs before signs and symptoms emerge. Although these technological improvements depict extraordinary development in being familiar with